Veterinary Blog for Education, Careers, and Real Vet Life

Welcome to the Vet Candy Blog—your go-to destination for veterinary education, career growth, and real-life insights from the world of animal health.

From free RACE-approved CE courses and clinical updates to NAVLE prep and career advice, our content is designed for veterinarians, vet techs, and students who want to stay informed, inspired, and ahead in their careers.

A young woman with curly hair smiling while looking at her phone in a bright indoor setting.

Latest Veterinary News & Clinical Insights

Mind-Blowing breakthrough: Canine cancer treatment that astonished even experts!
Clinical Updates Vet Candy Clinical Updates Vet Candy

Mind-Blowing breakthrough: Canine cancer treatment that astonished even experts!

In human medicine, intrathecal chemotherapy is a well-known treatment for central nervous system hematopoietic neoplasia. However, its application and benefits in veterinary medicine remain relatively unexplored. In this case report, we delve into the story of a 4-year-old male cross-breed dog who presented with concerning symptoms, leading to an intriguing use of intrathecal chemotherapy.

Read More
Shocking Revelation: The hidden truth about chemotherapy drug shortage
Clinical Updates Vet Candy Clinical Updates Vet Candy

Shocking Revelation: The hidden truth about chemotherapy drug shortage

The nationwide shortage of cancer chemotherapy medicines for pets is a pressing issue that affects both veterinary professionals and the pets they care for. Addressing this problem requires collaboration among pharmaceutical companies, regulatory agencies, veterinarians, and pet owners. By working together, we can ensure that our animal companions receive the best possible care in their battle against cancer, and we can alleviate the burden on the veterinary community.

Read More
Clinical Updates Vet Candy Clinical Updates Vet Candy

BREAKING: New cancer drug holds hope for man's best friend - Could this be the cure we've been waiting for?

A groundbreaking multi-center clinical trial funded by the Bernese Mountain Dog Club of America is set to evaluate the potential of a cancer drug to control tumor growth and improve outcomes for dogs with histiocytic sarcoma, a typically fatal canine cancer. Dr. Vilma Yuzbasiyan-Gurkan, the study's Principal Investigator, shares her excitement about the targeted approach using the drug trametinib, showing promising results in tests against canine sarcoma cell lines and mouse models.

Read More

Your Questions, Answered